CLINICAL AND MORPHOLOGICAL CHARACTERISTICS AND SURGICAL TREATMENT OUTCOMES OF OVARIAN CANCER IN WOMEN WITH CONCOMITANT CERVICAL PATHOLOGY

Background. Ovarian cancer remains one of the most significant challenges in modern gynecologic oncology due to the high prevalence of advanced-stage disease, the complexity of surgical treatment, and the risk of recurrence. Selecting the optimal extent of surgical intervention in patients with concomitant cervical diseases is of particular importance.

Objective. To investigate the clinical and morphological characteristics of ovarian cancer in women with concomitant cervical pathology and to evaluate the immediate outcomes of different types of surgical treatment.

Materials and Methods. A hypothetical comparative study model involving 150 patients with ovarian cancer was developed. Group I included 75 women without concomitant cervical pathology, while Group II consisted of 75 patients with pathological changes of the cervix. The proposed analysis included patient age, reproductive history, disease stage, histological tumor type, extent of surgical intervention, and postoperative complications.

Results. In the illustrative study population, women aged 50–59 years predominated in both groups, accounting for 34.7% in Group I and 32.0% in Group II. Concomitant cervical ectopy was observed in 40.0% of cases, while chronic cervicitis accounted for 26.7%. Total hysterectomy with bilateral salpingo-oophorectomy as part of cytoreductive surgery was represented in 54.7% of cases, while cytoreductive procedures involving additional abdominal organ surgery accounted for 28.7%. The hypothetical incidence of early postoperative complications was 18.0%.

Conclusion. The selection of surgical treatment strategies for ovarian cancer should be based on the extent of tumor spread, the feasibility of achieving complete macroscopic cytoreduction, and the individual clinical and morphological characteristics of each patient. Concomitant cervical pathology requires timely diagnosis and appropriate follow-up.